Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

被引：0
|
作者：
Amanda Hansson-Hedblom
Isabelle Axelsson
Lena Jacobson
Joakim Tedroff
Fredrik Borgström
机构：
[1] Quantify Research AB,
[2] Allergan Norden AB,undefined
[3] Neuroenheten Utsikten,undefined
来源：
The Journal of Headache and Pain | 2020年 / 21卷
关键词：
Migraine; Headache; onabotulinumtoxinA; Botox; Cost-effectiveness; Cost of illness; Burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
    Hansson-Hedblom, Amanda
    Axelsson, Isabelle
    Jacobson, Lena
    Tedroff, Joakim
    Borgstrom, Fredrik
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [2] Cost-effectiveness analysis of erenumab vs onabotulinumtoxinA for chronic migraine in Spain
    Pozo-Rosich, Patricia
    Poveda, Jose Luis
    Sanchez, Sergio
    Crespo, Carlos
    Martinez, Maria
    Irimia, Pablo
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 118 - 119
  • [3] COST-EFFECTIVENESS OF ONABOTULINUMTOXINA FOR PROPHYLAXIS OF HEADACHES IN ADULTS WITH CHRONIC MIGRAINE IN CANADA
    Bloudek, L. M.
    Hansen, R. N.
    Sanderson, J. C.
    Kan, L.
    Petrovic, G.
    Varon, S. F.
    Sullivan, S. D.
    VALUE IN HEALTH, 2013, 16 (03) : A105 - A105
  • [4] The cost effectiveness of Botox in Italian patients with chronic migraine
    Ruggeri, M.
    NEUROLOGICAL SCIENCES, 2014, 35 : S45 - S47
  • [5] The cost effectiveness of Botox in Italian patients with chronic migraine
    M. Ruggeri
    Neurological Sciences, 2014, 35 : 45 - 47
  • [6] Cost-Effectiveness of Initial Prophylactic Treatment of Chronic Migraine: Oral Medications versus OnabotulinumtoxinA
    Kelley, Kristin
    Schoenbrunner, Anna
    Murphy, James
    NEUROLOGY, 2016, 86
  • [7] Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece
    Theodoros V. Giannouchos
    Dimos-Dimitrios Mitsikostas
    Robert L. Ohsfeldt
    Athanassios Vozikis
    Paraskevi Koufopoulou
    Clinical Drug Investigation, 2019, 39 : 979 - 990
  • [8] Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece
    Giannouchos, Theodoros V.
    Mitsikostas, Dimos-Dimitrios
    Ohsfeldt, Robert L.
    Vozikis, Athanassios
    Koufopoulou, Paraskevi
    CLINICAL DRUG INVESTIGATION, 2019, 39 (10) : 979 - 990
  • [9] Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden
    Mahon, Ronan
    Lang, Andrea
    Vo, Pamela
    Huels, Jasper
    Cooney, Philip
    Danyliv, Andriy
    Vudumula, Umakanth
    Vadapalle, Sreelatha
    Maniyar, Farooq
    Goadsby, Peter J.
    PHARMACOECONOMICS, 2021, 39 (03) : 357 - 372
  • [10] Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden
    Ronan Mahon
    Andrea Lang
    Pamela Vo
    Jasper Huels
    Philip Cooney
    Andriy Danyliv
    Umakanth Vudumula
    Sreelatha Vadapalle
    Farooq Maniyar
    Peter J. Goadsby
    PharmacoEconomics, 2021, 39 : 357 - 372
12345